| Drug Name |
Cyclobenzaprine |
| Drug ID |
BADD_D00545 |
| Description |
Cyclobenzaprine, a centrally-acting muscle relaxant, was first synthesized in 1961[A185039] and has been available for human use since 1977.[A184982] It was initially studied for use as antidepressant given its structural similarity to tricyclic antidepressants - it differs from [Amitriptyline] by only a single double bond.[A185039,A184982] Since its approval, it has remained relatively popular as an adjunctive, short-term treatment for acute skeletal muscle spasms secondary to musculoskeletal injury. |
| Indications and Usage |
For use as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
M03BX08 |
| DrugBank ID |
DB00924
|
| KEGG ID |
D07758
|
| MeSH ID |
C004704
|
| PubChem ID |
2895
|
| TTD Drug ID |
D01KHH
|
| NDC Product Code |
68071-3150; 63187-812; 0615-8084; 61919-305; 69097-845; 69097-846; 51927-0118; 70518-0635; 58118-0846; 53002-3080; 53002-0521; 67296-1728; 70518-3159; 68071-3154; 60687-558; 50090-3253; 70934-005; 70518-0082 |
| Synonyms |
cyclobenzaprine | Flexeril | Lisseril | cyclobenzaprine hydrochloride |
